SAB Biotherapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SABSW | ABUS | SANA | CMMB | BMY | ZURA | |
|---|---|---|---|---|---|---|
| Market cap | — | 648.36M | 669.07M | 9.27M | 120.53B | 371.82M |
| P/E (TTM) | 0.0 | 5.4 | — | — | 13.0 | — |
| Forward P/E | — | -25.6 | -4.0 | -42.2 | 8.9 | -5.6 |
| Price/book | 0.0 | 3.2 | 4.3 | 1.1 | 5.4 | 1.9 |
| Dividend yield | — | — | — | — | 4.22% | — |
| 1-year change | — | −7.25% | −59.17% | −62.79% | +37.07% | +15.13% |
| Today | −31.43% | +0.24% | −1.54% | −1.94% | −1.25% | −9.35% |
The closest companies by business. Prices may be delayed up to 15 min.
Latest news
All SABSW news ›Critical Contrast: Tonix Pharmaceuticals (NASDAQ:TNXP) vs. SAB Biotherapeutics (NASDAQ:SABS)
Posted by Defense World Staff on Oct 8th, 2026 SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) and Tonix Pharmaceuticals (NASDAQ:TNXP – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
defenseworld.net1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.